ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,493Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 161

$2.82M Total Retail Price of All Prescriptions

Rank: 1 out of 161

449 Patients Receiving at Least One Drug in Part D
26%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

91% of this provider’s 449 patients filled at least one prescription for a schedule two drug, compared to an average of 51%.

Schedule Three
Controlled Substances

31% of this provider’s 449 patients filled at least one prescription for a schedule three drug, compared to an average of 30%.

Risky Drugs to Seniors

6% of this provider’s 2,872 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$194 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OXYCODONE HCL 2,410 622 S2 1 3
CARISOPRODOL 1,148 112 R 2 10
HYDROMORPHONE HCL 1,095 173 S2 10 3 14
MORPHINE SULFATE ER 934 152 S2 4 4
METHADONE HCL 906 196 S2 5 7
HYDROCODONE-ACETAMINOPHEN 859 292 S3 6 1
OXYCONTIN 811 168 S2 7 11
OXYCODONE HCL-ACETAMINOPHEN 437 136 S2 8 5
MORPHINE SULFATE 427 40 S2 9 13
FENTANYL 340 51 S2 10 8
ZOLPIDEM TARTRATE 196 52 11 19
TIZANIDINE HCL 195 25 12 12
GABAPENTIN 191 25 13 2
ALPRAZOLAM 176 47 14 31
TRAZODONE HCL 163 23 15 35
PROMETHAZINE HCL 157 0 R 16 34
CYCLOBENZAPRINE HCL 134 23 R 17 17
LYRICA 128 0 18 16
BUPROPION HCL 108 0 19 55
IBUPROFEN 106 0 20 28
SUMATRIPTAN SUCCINATE 102 0 21 44
CYMBALTA 94 0 22 22
FENTANYL CITRATE 93 24 S2 10 23 58
ENDOCET 90 32 S2 24 20
SERTRALINE HCL 88 11 25 59
LIDODERM 87 29 26 21
DIAZEPAM 84 43 27 37
METHYLPHENIDATE HCL 81 20 28 60
CITALOPRAM HBR 72 0 29 54
OPANA ER 72 0 S2 29 33
AMPHETAMINE SALT COMBO 71 16 S2 31 66
BUTALB-CAFF-ACETAMINOPH-CODEIN 66 0 S3 R 10 32 68
METHOCARBAMOL 64 0 R 33 24
ZOLPIDEM TARTRATE ER 60 15 34 72
OXYCODONE CONCENTRATE 59 0 S2 35 73
CIPROFLOXACIN HCL 57 11 36 75
HYDROCODONE BIT-IBUPROFEN 56 0 S3 37 45
AMITRIPTYLINE HCL 53 14 R 38 23
TRAMADOL HCL 51 21 39 6
MELOXICAM 50 0 40 15
OXYCODONE-ACETAMINOPHEN 50 16 S2 40 9
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.